TRPC3 and prostate cancer: Based on the observed findings, L687 may be effective as a drug delivery system (DDS) for the selective delivery of ASO to lung or prostate cancer tissues, given that L687 was thought to promote the selective uptake of ASO in cells with high TRPC3/C6 expression.